The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review

OBJECTIVE: Over the last few decades clinicians have become aware that cognitive impairment might be a major cause of disability, loss of employment and poor quality of life in patients suffering from multiple sclerosis [MS]. The impact of disease modifying therapies [DMTs] on cognition is still a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kania, Karolina, Ambrosius, Wojciech, Kozubski, Wojciech, Kalinowska-Łyszczarz, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368887/
https://www.ncbi.nlm.nih.gov/pubmed/37503514
http://dx.doi.org/10.3389/fneur.2023.1222574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368887/
https://www.ncbi.nlm.nih.gov/pubmed/37503514
http://dx.doi.org/10.3389/fneur.2023.1222574

Ejemplares similares